Takeda ditches late-stage Ninlaro trial

6th June 2019 Uncategorised 0

The company remains “optimistic about Ninlaro and continue to investigate Ninlaro in patient populations across the continuum of multiple myeloma care”.

More: Takeda ditches late-stage Ninlaro trial
Source: News